Form 4: Northrop Grumman Executive Benjamin R. Davies Reports Stock Transactions
SEC Form 4 Filing
Benjamin R. Davies, CVP & President of Defense Systems at Northrop Grumman, reports transactions involving common stock and derivative securities, including acquisitions, disposals, and vesting of restricted stock rights.
Summary
- On February 18, 2025, Benjamin R. Davies, a CVP & President of Defense Systems at Northrop Grumman, filed a Form 4 detailing changes in beneficial ownership of company stock.
- The transactions included the acquisition and disposal of common stock, as well as the vesting and granting of Restricted Performance Stock Rights (RPSRs) and Restricted Stock Rights (RSRs).
- Davies disposed of 293 shares of common stock at $445.35 per share.
- He also acquired 5,399.8 RPSRs and 2,456 RSRs, both granted on February 18, 2025.
- Some of these transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 6, 2024.
- The reported transactions also reflect shares held in the Northrop Grumman Savings Plan.
Sentiment
Score: 6
Explanation: The document is a routine filing of executive stock transactions. While the sale of shares could be perceived negatively, the overall sentiment is neutral as it is part of a pre-arranged trading plan and includes the granting of new stock rights.
Positives
- The granting of RPSRs and RSRs to Davies suggests continued alignment of his interests with the long-term performance of Northrop Grumman.
- The vesting of previously granted stock rights indicates that performance metrics were met, which is a positive sign for the company's performance.
Negatives
- The sale of 293 shares by Davies, while part of a pre-arranged trading plan, could be interpreted negatively by some investors if not understood in context.
Risks
- The value of RPSRs and RSRs is contingent on the future performance of Northrop Grumman's stock and the satisfaction of performance metrics.
- Changes in company performance or market conditions could impact the value of these derivative securities.
Future Outlook
The document details future vesting dates for RSRs and performance periods for RPSRs, indicating a multi-year incentive structure for the reporting person.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and are closely watched by investors for insights into management's perspective on the company's prospects.
Comparison to Industry Standards
- Executive compensation packages at companies like Lockheed Martin (LMT) and General Dynamics (GD) also include stock options, restricted stock units, and performance-based incentives.
- The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to avoid accusations of insider trading.
- The vesting schedules and performance metrics associated with RPSRs and RSRs are typically aligned with industry benchmarks for executive compensation.
Stakeholder Impact
- Shareholders may be interested in the executive's stock transactions as an indicator of management's confidence in the company.
- Employees may view the granting of stock rights as a positive sign of the company's commitment to employee compensation and alignment of interests.
Next Steps
- Monitor future Form 4 filings by Davies to track changes in his beneficial ownership of Northrop Grumman stock.
- Assess the company's performance against the metrics associated with the RPSRs to evaluate the effectiveness of the incentive plan.
Key Dates
| Date | Description |
|---|---|
| August 6, 2024 | Date the reporting person adopted a Rule 10b5-1 trading plan. |
| February 18, 2025 | Date of the reported transactions, including stock sales, RPSR/RSR grants, and vesting. |
| February 20, 2025 | Date of the Form 4 filing. |
Keywords
Northrop Grumman, NOC, Form 4, Benjamin R. Davies, Stock Transactions, Restricted Stock Rights, Restricted Performance Stock Rights, Rule 10b5-1, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.